GoalKeeper: Intelligent Information Sharing for Children With Medical Complexity

Cerebral Palsy Clinical Trial

— GoalKeeper  

Official title:

Intelligent Information Sharing: Advancing Teamwork in Complex Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03620071
• Other study ID #: 1R01CA204585-01
• Secondary ID: 1R01CA204585-01
• Status: Completed
• Phase: N/A
• Start date: April 19, 2019
• Est. completion date: March 17, 2021

Study information

• Verified date: September 2023
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This proposal addresses the major challenge of improving health outcomes for children with cancer and other complex conditions, for whom the effectiveness of outpatient care depends on care coordination across a diverse group of caregivers that includes parents, community support organizations and pediatric care providers. The investigators have developed GoalKeeper, a prototype system for supporting care coordination across multiple care providers. The primary aim of the clinical trial is to assess the potential for this new system, GoalKeeper, to improve meaningful use of goal-centered care plans in the care of children with cancer and other complex chronic conditions.

Description:

The overarching aim of the research is to improve care coordination and goal setting for children with medical complexity (CMC). Specific aims of the pilot clinical trail are as follows: (1) To assess the efficacy of GoalKeeper on goal-setting in the health care encounter. (2) To examine the roles of parent health literacy and parent activation in moderating the effect of the intervention. Study Population: Stanford's Primary and Subspecialty Care Clinics at Stanford Children's Health will serve as the setting for study recruitment. The pilot randomized controlled trial will enroll 60 parents of children with medical complexity and their health-care providers. Eligibility criteria for participants will be age 18 years or older, English-speaking, and (for parents) child<12 years old. Exclusion criteria are parent with known mental illness or neurocognitive impairment. A stepped wedge approach by provider will introduce families to GoalKeeper at different time points in the study. A pre-intervention period will occur at least 1 month before the trial start where clinical observations and baseline survey information will be obtained of each providers' practice. Each family will be given training and 4-month access to the GoalKeeper application and participate in an exit interview at the end of study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 67
• Est. completion date: March 17, 2021
• Est. primary completion date: January 19, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Parent-child dyads and their medical provider
• Parent and provider age 18 years or older
• Parent English- or Spanish-speaking
• Child > age 12 months and <12 years old

Exclusion Criteria:

• Parent with known mental illness or neurocognitive impairment.

Related Conditions & MeSH terms

• Cerebral Palsy
• Childhood Cancer
• Chronic Lung Disease
• Congenital Heart Disease
• Congenital Metabolic Disorder
• Gastrostomy
• Heart Defects, Congenital
• Heart Diseases
• Lung Diseases
• Metabolic Diseases
• Metabolism, Inborn Errors

Intervention

Other:
• GoalKeeper
Mobile-health communication tool for parents of children with medical complexity
• Standard Care
Standard Clinical Care

Locations

Country	Name	City	State
United States	Stanford Children's Health	Palo Alto	California

Sponsors (3)

Lead Sponsor	Collaborator
Stanford University	Harvard University, National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Lin JL, Clark CL, Halpern-Felsher B, Bennett PN, Assis-Hassid S, Amir O, Nunez YC, Cleary NM, Gehrmann S, Grosz BJ, Sanders LM. Parent Perspectives in Shared Decision-Making for Children With Medical Complexity. Acad Pediatr. 2020 Nov-Dec;20(8):1101-1108. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Change in parent perception of quality of shared decision making from baseline to 1 month	Parent perception will be measured using the "National Survey of Children with Special Health Care Needs Shared Decision Making Domain," which includes 4 domain items each with a scale of 1 (never), 2 (sometimes), 3 (usually) or 4 (always). Positive SDM is defined as parent report of "usually" or "always" on all 4 items. Shared decision making refers to a communication process where parents and providers participate in decision making to reach treatment plan agreement.	Baseline and 1-Month Follow-up
Primary	Change in Parent Perception of Goal-Centered Care questionnaire from Baseline to 1-Month Follow-up	Parent perception of goal-centered care will be measured using a modified version of the "Patient Assessment of Chronic Illness Care, Goal-Setting Domain" questionnaire, using a scale of 1(Almost Never) to 5 (Almost Always) with higher values representing better goal-centered care.	Baseline and 1-Month Follow-up
Secondary	Count of parent participants with change in perception of goal-centered care from baseline to 3-Month Follow-up based on Investigator assessment.	Change in perception in quality of goal-centered care will be assessed by Investigators based on parent baseline interviews and parent exit interviews.	Baseline and 3 month follow-up